New drug prevents flu-related inflammation and lung damage

Findings show a newly created drug can prevent runaway inflammation while still allowing the immune system to handle the virus, even when given late into infect

Related Keywords

Julius Beer ,Brandi Livingston ,Gregory Cuny ,Paul Thomas ,Deutsche Forschungsgemeinschaft ,Siddharth Balachandran ,Avishekh Gautam ,Kathy Cai ,Daniel Schnepf ,Diego Rodriguez ,Bikash Thapa ,Carly Deantoneo ,Martin Schwemmle ,Seungheon Lee ,Christian Loch ,Dingqiang Zhang ,Riley Williams ,Anantha Duddupudi ,Jessica Gaevert ,Sameer Nikhar ,Ioannis Siokas ,Lawrence Fritz ,David Boyd ,Peter Vogel ,Maria Shubina ,Alexei Degterev ,Rae Lyn Hartley ,Raghavender Boda ,Stacey Schultz ,University Of Freiburg ,Jude Children Research Hospital ,Fox Chase Cancer Center ,Collaborative Influenza Vaccine Innovation Centers ,Jude Center ,National Institutes Of Health ,Jude Department Of Host ,Influenza Research ,University Of Houston ,Tufts University School Of Medicine ,Human Services ,Jude Children ,Research Hospital ,Tufts University School ,Jude Department ,Receptor Interacting Protein Kinase ,Fox Chase Cancer ,Ting Zhang ,Chaoran Yin ,Reaction Biology ,Lee Ann Van De Velde ,Victoria Meliopoulos ,Jeremy Chase Crawford ,Stacey Schultz Cherry ,Douglas Green ,National Institutes ,Influenza Disease ,Emergence Response ,Sheffield Desk ,